Organ Preservation Solution Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Organ Type (Heart, Lung, Kidney, Liver, Others), By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others), By Region and Competition, 2019-2029F
Global Organ Preservation Solution Market was valued at USD 257.35 million in 2023 and is anticipated t%li%project impressive growth in the forecast period with a CAGR of 6.62% through 2029. Organ preservation solutions play a crucial role in maintaining the viability of donated organs during the entire process, from procurement t%li%transplantation. With the increasing number of individuals in need of organ transplants, there is a growing demand for these solutions. This demand, coupled with constant technological advancements in the field, has been instrumental in driving the market's growth.
Also, the market's expansion is propelled by the rising prevalence of chronic diseases that often result in organ failure. For instance, the surge in cases of kidney and liver diseases has directly contributed t%li%an increase in the number of transplants, consequently boosting the demand for effective organ preservation solutions.
However, the market als%li%faces certain challenges. One major obstacle is the high cost associated with organ transplantation procedures and the preservation solutions themselves. Additionally, the shortage of organ donors poses a significant hindrance t%li%the market's growth. Despite these challenges, ongoing research and development efforts continue t%li%focus on finding innovative solutions and strategies t%li%overcome these barriers and ensure the availability of viable organs for transplantation.
Key Market Drivers
Growing Number of Organ Transplant Procedures
The number of organ transplant procedures has been steadily increasing each year, setting remarkable all-time records. In 2021 alone, a total of 41,354 organ transplants were performed in the United States, representing an impressive increase of 5.9 percent compared t%li%the previous year. This positive trend continued t%li%surge in 2022, with over 42,800 organ transplants successfully carried out, setting yet another annual record.
The significance of organ preservation solutions cannot be overstated, as they play a vital role in maintaining the viability of donated organs from the moment of procurement all the way through transplantation. As the demand for organ transplants continues t%li%rise, driven by the growing number of individuals in need, the demand for these preservation solutions als%li%rises in tandem. This increasing demand, coupled with remarkable technological advancements in the field, has been instrumental in propelling the overall growth of the market.
Moreover, the rising prevalence of chronic diseases leading t%li%organ failure further underscores the crucial need for organ transplants. For example, there has been a surge in cases of kidney and liver diseases, resulting in a corresponding increase in the number of transplants performed. Consequently, this surge in transplants further intensifies the demand for effective organ preservation solutions, which are essential in ensuring the success and viability of these life-saving procedures.
Rise in Healthcare Expenditure
Healthcare expenditure worldwide has been on an upward trajectory for several years, driven by various factors. One significant factor is the aging population, as the number of elderly individuals requiring healthcare services continues t%li%rise. Additionally, the increase in chronic diseases, such as cardiovascular conditions and diabetes, has contributed t%li%the growing healthcare expenditure.
Also, advancements in medical technologies have played a crucial role in driving up healthcare costs. The development of innovative treatments and therapies, including precision medicine and gene therapies, has opened up new possibilities for patients but als%li%comes with a higher price tag. Increased public health spending has contributed t%li%the overall rise in healthcare expenditure. Governments around the world are recognizing the importance of investing in public health infrastructure and preventive measures t%li%curb the spread of diseases and improve the overall well-being of their populations.
As healthcare expenditure continues t%li%rise, the demand for organ transplants has als%li%increased significantly. Organ preservation solutions play a vital role in maintaining the viability of donated organs throughout the entire transplantation process. With the prevalence of organ failures due t%li%chronic diseases on the rise, the need for organ transplants has become more urgent than ever before.
The increase in healthcare expenditure has enabled more patients t%li%afford life-saving organ transplant procedures, thereby further boosting the demand for organ preservation solutions. This, in turn, has led t%li%increased investments in research and development (R&D) of advanced organ preservation technologies. For example, the development of normothermic perfusion techniques, which allow organs t%li%be preserved at body temperature, has revolutionized the field of transplantation. These advancements in organ preservation technologies are made possible by the availability of increased funding for R&D, which further drives the growth of the organ preservation solution market.
The rise in healthcare expenditure worldwide is driven by various factors, including the aging population, the increase in chronic diseases, advancements in medical technologies, and increased public health spending. As healthcare expenditure continues t%li%increase, the demand for organ transplants rises, leading t%li%the growth of the organ preservation solution market. The availability of advanced organ preservation technologies, facilitated by increased investments in R&D, is transforming the field of transplantation and improving patient outcomes.
Key Market Challenges
High Cost of Organ Preservation Solutions
Organ preservation solutions play a critical role in ensuring the viability of donated organs throughout the entire process, from procurement t%li%transplantation. As the demand for organ transplants continues t%li%rise, the importance of these solutions becomes increasingly evident. However, the high costs associated with these solutions can pose significant challenges for many healthcare systems and patients, potentially impeding market growth.
The process of organ transplantation is a complex and costly endeavor that goes beyond the actual surgery itself. It encompasses various aspects, including organ procurement, preservation, and post-operative care. Among these, the organ preservation segment alone can account for a substantial portion of the overall costs involved.
For instance, in the United States, the average cost of preserving a kidney is estimated t%li%be around USD 20,000. When it comes t%li%more intricate organs like the heart and lungs, the costs can escalate even further. Such high expenses can exert considerable pressure on healthcare budgets and may prove t%li%be prohibitive for patients residing in countries where healthcare costs are not fully covered by public health systems or insurance.
Given these challenges, finding innovative approaches t%li%reduce the costs associated with organ preservation solutions is crucial. This would not only enhance accessibility t%li%transplantation for patients in need but als%li%alleviate the burden on healthcare systems worldwide.
Key Market Trends
Growing Demand of Biological and Synthetic Solutions
Biological and synthetic preservation solutions play a crucial role in maintaining the viability of donated organs from procurement t%li%transplantation. The science of organ preservation is constantly being updated with new knowledge and ideas, leading t%li%the development of more effective and efficient preservation solutions.
Biological solutions leverage the body's natural processes t%li%preserve organs. One example is the use of blood or its components, such as red blood cells and plasma. These components not only provide essential nutrients and oxygen t%li%the organ but als%li%help t%li%minimize damage during the preservation process by stabilizing the pH levels and preventing the formation of harmful free radicals. Additionally, biological solutions may include the use of cryoprotectants, which are substances that protect the cells and tissues from damage caused by freezing temperatures.
On the other hand, synthetic solutions are specifically designed t%li%mimic the ideal conditions for organ preservation. These solutions often contain a balanced mix of electrolytes, nutrients, and other compounds that help t%li%maintain organ function and structure. For example, synthetic preservation solutions may include antioxidants t%li%protect against oxidative stress, as well as osmotic agents t%li%maintain proper cellular hydration.
By continuously refining and optimizing both biological and synthetic preservation solutions, researchers and medical professionals aim t%li%improve the success rates of organ transplantation and ultimately save more lives. Through ongoing research and innovation, the field of organ preservation continues t%li%evolve, ensuring that donated organs remain viable and functional for transplantation, giving hope t%li%patients in need of life-saving procedures.
Segmental Insights
Application Insights
The static cold storage segment is projected t%li%experience rapid growth during the forecast period. Static cold storage has been a long-standing and reliable method of organ preservation in the medical community. This traditional approach involves carefully cooling the organ t%li%slow down its metabolic processes. By reducing the rate of tissue decay, transplant teams are afforded valuable time t%li%thoroughly prepare and execute the procedure.
In comparison t%li%newer preservation techniques like normothermic perfusion, the static cold storage method remains a popular choice due t%li%its simplicity and cost-effectiveness. Hospitals and clinics worldwide find it accessible, as it requires less specialized equipment and training. This accessibility ensures that organ preservation can be implemented effectively, benefiting patients in need of life-saving transplants.
Regional Insights
North America emerged as the dominant region in the Global Organ Preservation Solution Market in 2023, holding the largest market share in terms of value. In recent years, the region has witnessed a significant surge in cases of multi-organ failures, posing a challenge t%li%the healthcare system. Additionally, there has been a noticeable shift in demographics, with a growing geriatric population that requires specialized care and attention. As a result, this has created an unprecedented demand for organ transplants and preservation techniques t%li%meet the healthcare needs of the population.
When it comes t%li%North America, particularly the United States, the healthcare infrastructure stands out as a shining example of excellence. With its well-established medical facilities, advanced technology, and highly skilled healthcare professionals, the region is equipped t%li%handle the intricate complexities of organ transplantation and preservation. This robust healthcare system ensures that patients have access t%li%the necessary resources and expertise, ensuring optimal outcomes for those in need of life-saving procedures.
Key Market Players
In this report, the Global Organ Preservation Solution Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Solution Market.
Available Customizations:
Global Organ Preservation Solution Market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Also, the market's expansion is propelled by the rising prevalence of chronic diseases that often result in organ failure. For instance, the surge in cases of kidney and liver diseases has directly contributed t%li%an increase in the number of transplants, consequently boosting the demand for effective organ preservation solutions.
However, the market als%li%faces certain challenges. One major obstacle is the high cost associated with organ transplantation procedures and the preservation solutions themselves. Additionally, the shortage of organ donors poses a significant hindrance t%li%the market's growth. Despite these challenges, ongoing research and development efforts continue t%li%focus on finding innovative solutions and strategies t%li%overcome these barriers and ensure the availability of viable organs for transplantation.
Key Market Drivers
Growing Number of Organ Transplant Procedures
The number of organ transplant procedures has been steadily increasing each year, setting remarkable all-time records. In 2021 alone, a total of 41,354 organ transplants were performed in the United States, representing an impressive increase of 5.9 percent compared t%li%the previous year. This positive trend continued t%li%surge in 2022, with over 42,800 organ transplants successfully carried out, setting yet another annual record.
The significance of organ preservation solutions cannot be overstated, as they play a vital role in maintaining the viability of donated organs from the moment of procurement all the way through transplantation. As the demand for organ transplants continues t%li%rise, driven by the growing number of individuals in need, the demand for these preservation solutions als%li%rises in tandem. This increasing demand, coupled with remarkable technological advancements in the field, has been instrumental in propelling the overall growth of the market.
Moreover, the rising prevalence of chronic diseases leading t%li%organ failure further underscores the crucial need for organ transplants. For example, there has been a surge in cases of kidney and liver diseases, resulting in a corresponding increase in the number of transplants performed. Consequently, this surge in transplants further intensifies the demand for effective organ preservation solutions, which are essential in ensuring the success and viability of these life-saving procedures.
Rise in Healthcare Expenditure
Healthcare expenditure worldwide has been on an upward trajectory for several years, driven by various factors. One significant factor is the aging population, as the number of elderly individuals requiring healthcare services continues t%li%rise. Additionally, the increase in chronic diseases, such as cardiovascular conditions and diabetes, has contributed t%li%the growing healthcare expenditure.
Also, advancements in medical technologies have played a crucial role in driving up healthcare costs. The development of innovative treatments and therapies, including precision medicine and gene therapies, has opened up new possibilities for patients but als%li%comes with a higher price tag. Increased public health spending has contributed t%li%the overall rise in healthcare expenditure. Governments around the world are recognizing the importance of investing in public health infrastructure and preventive measures t%li%curb the spread of diseases and improve the overall well-being of their populations.
As healthcare expenditure continues t%li%rise, the demand for organ transplants has als%li%increased significantly. Organ preservation solutions play a vital role in maintaining the viability of donated organs throughout the entire transplantation process. With the prevalence of organ failures due t%li%chronic diseases on the rise, the need for organ transplants has become more urgent than ever before.
The increase in healthcare expenditure has enabled more patients t%li%afford life-saving organ transplant procedures, thereby further boosting the demand for organ preservation solutions. This, in turn, has led t%li%increased investments in research and development (R&D) of advanced organ preservation technologies. For example, the development of normothermic perfusion techniques, which allow organs t%li%be preserved at body temperature, has revolutionized the field of transplantation. These advancements in organ preservation technologies are made possible by the availability of increased funding for R&D, which further drives the growth of the organ preservation solution market.
The rise in healthcare expenditure worldwide is driven by various factors, including the aging population, the increase in chronic diseases, advancements in medical technologies, and increased public health spending. As healthcare expenditure continues t%li%increase, the demand for organ transplants rises, leading t%li%the growth of the organ preservation solution market. The availability of advanced organ preservation technologies, facilitated by increased investments in R&D, is transforming the field of transplantation and improving patient outcomes.
Key Market Challenges
High Cost of Organ Preservation Solutions
Organ preservation solutions play a critical role in ensuring the viability of donated organs throughout the entire process, from procurement t%li%transplantation. As the demand for organ transplants continues t%li%rise, the importance of these solutions becomes increasingly evident. However, the high costs associated with these solutions can pose significant challenges for many healthcare systems and patients, potentially impeding market growth.
The process of organ transplantation is a complex and costly endeavor that goes beyond the actual surgery itself. It encompasses various aspects, including organ procurement, preservation, and post-operative care. Among these, the organ preservation segment alone can account for a substantial portion of the overall costs involved.
For instance, in the United States, the average cost of preserving a kidney is estimated t%li%be around USD 20,000. When it comes t%li%more intricate organs like the heart and lungs, the costs can escalate even further. Such high expenses can exert considerable pressure on healthcare budgets and may prove t%li%be prohibitive for patients residing in countries where healthcare costs are not fully covered by public health systems or insurance.
Given these challenges, finding innovative approaches t%li%reduce the costs associated with organ preservation solutions is crucial. This would not only enhance accessibility t%li%transplantation for patients in need but als%li%alleviate the burden on healthcare systems worldwide.
Key Market Trends
Growing Demand of Biological and Synthetic Solutions
Biological and synthetic preservation solutions play a crucial role in maintaining the viability of donated organs from procurement t%li%transplantation. The science of organ preservation is constantly being updated with new knowledge and ideas, leading t%li%the development of more effective and efficient preservation solutions.
Biological solutions leverage the body's natural processes t%li%preserve organs. One example is the use of blood or its components, such as red blood cells and plasma. These components not only provide essential nutrients and oxygen t%li%the organ but als%li%help t%li%minimize damage during the preservation process by stabilizing the pH levels and preventing the formation of harmful free radicals. Additionally, biological solutions may include the use of cryoprotectants, which are substances that protect the cells and tissues from damage caused by freezing temperatures.
On the other hand, synthetic solutions are specifically designed t%li%mimic the ideal conditions for organ preservation. These solutions often contain a balanced mix of electrolytes, nutrients, and other compounds that help t%li%maintain organ function and structure. For example, synthetic preservation solutions may include antioxidants t%li%protect against oxidative stress, as well as osmotic agents t%li%maintain proper cellular hydration.
By continuously refining and optimizing both biological and synthetic preservation solutions, researchers and medical professionals aim t%li%improve the success rates of organ transplantation and ultimately save more lives. Through ongoing research and innovation, the field of organ preservation continues t%li%evolve, ensuring that donated organs remain viable and functional for transplantation, giving hope t%li%patients in need of life-saving procedures.
Segmental Insights
Application Insights
The static cold storage segment is projected t%li%experience rapid growth during the forecast period. Static cold storage has been a long-standing and reliable method of organ preservation in the medical community. This traditional approach involves carefully cooling the organ t%li%slow down its metabolic processes. By reducing the rate of tissue decay, transplant teams are afforded valuable time t%li%thoroughly prepare and execute the procedure.
In comparison t%li%newer preservation techniques like normothermic perfusion, the static cold storage method remains a popular choice due t%li%its simplicity and cost-effectiveness. Hospitals and clinics worldwide find it accessible, as it requires less specialized equipment and training. This accessibility ensures that organ preservation can be implemented effectively, benefiting patients in need of life-saving transplants.
Regional Insights
North America emerged as the dominant region in the Global Organ Preservation Solution Market in 2023, holding the largest market share in terms of value. In recent years, the region has witnessed a significant surge in cases of multi-organ failures, posing a challenge t%li%the healthcare system. Additionally, there has been a noticeable shift in demographics, with a growing geriatric population that requires specialized care and attention. As a result, this has created an unprecedented demand for organ transplants and preservation techniques t%li%meet the healthcare needs of the population.
When it comes t%li%North America, particularly the United States, the healthcare infrastructure stands out as a shining example of excellence. With its well-established medical facilities, advanced technology, and highly skilled healthcare professionals, the region is equipped t%li%handle the intricate complexities of organ transplantation and preservation. This robust healthcare system ensures that patients have access t%li%the necessary resources and expertise, ensuring optimal outcomes for those in need of life-saving procedures.
Key Market Players
- Waters Medical Systems LLC
- Xviv%li%Perfusion AB
- TransMedics Inc
- Organox Limited
- 21st Century Medicine
- Dr. Franz Koehler Chemie GmbH
- Accord Healthcare Limited
- Bridge t%li%Life Ltd
- Perfusion Solutions, Inc.
- Lifeline Scientific Inc.
In this report, the Global Organ Preservation Solution Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Organ Preservation Solution Market, By Product:
- Heart
- Lung
- Kidney
- Liver
- Others
- Organ Preservation Solution Market, By Application:
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
- Organ Preservation Solution Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Solution Market.
Available Customizations:
Global Organ Preservation Solution Market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. IMPACT OF COVID-19 ON GLOBAL ORGAN PRESERVATION SOLUTION MARKET
5. GLOBAL ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Organ Type (Heart, Lung, Kidney, Liver, Others)
5.2.2. By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others)
5.2.3. By Region
5.2.4. By Company (2023)
5.3. Market Map
6. ASIA PACIFIC ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Organ Type
6.2.2. By Application
6.2.3. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Organ Preservation Solution Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Organ Type
6.3.1.2.2. By Application
6.3.2. India Organ Preservation Solution Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Organ Type
6.3.2.2.2. By Application
6.3.3. Australia Organ Preservation Solution Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Organ Type
6.3.3.2.2. By Application
6.3.4. Japan Organ Preservation Solution Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Organ Type
6.3.4.2.2. By Application
6.3.5. South Korea Organ Preservation Solution Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Organ Type
6.3.5.2.2. By Application
7. EUROPE ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Organ Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Organ Preservation Solution Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Organ Type
7.3.1.2.2. By Application
7.3.2. Germany Organ Preservation Solution Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Organ Type
7.3.2.2.2. By Application
7.3.3. Spain Organ Preservation Solution Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Organ Type
7.3.3.2.2. By Application
7.3.4. Italy Organ Preservation Solution Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Organ Type
7.3.4.2.2. By Application
7.3.5. United Kingdom Organ Preservation Solution Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Organ Type
7.3.5.2.2. By Application
8. NORTH AMERICA ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Organ Type
8.2.2. By Application
8.2.3. By Country
8.3. North America: Country Analysis
8.3.1. United States Organ Preservation Solution Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Organ Type
8.3.1.2.2. By Application
8.3.2. Mexico Organ Preservation Solution Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Organ Type
8.3.2.2.2. By Application
8.3.3. Canada Organ Preservation Solution Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Organ Type
8.3.3.2.2. By Application
9. SOUTH AMERICA ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Organ Type
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Organ Preservation Solution Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Organ Type
9.3.1.2.2. By Application
9.3.2. Argentina Organ Preservation Solution Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Organ Type
9.3.2.2.2. By Application
9.3.3. Colombia Organ Preservation Solution Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Organ Type
9.3.3.2.2. By Application
10. MIDDLE EAST AND AFRICA ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Organ Type
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Organ Preservation Solution Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Organ Type
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Organ Preservation Solution Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Organ Type
10.3.2.2.2. By Application
10.3.3. UAE Organ Preservation Solution Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Organ Type
10.3.3.2.2. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. PESTLE ANALYSIS
16. COMPETITIVE LANDSCAPE
16.1. Waters Medical Systems LLC
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.2. Xvivo Perfusion AB
16.3. TransMedics Inc
16.4. Organox Limited
16.5. 21st Century Medicine
16.6. Dr. Franz Koehler Chemie GmbH
16.7. Accord Healthcare Limited
16.8. Bridge to Life Ltd
16.9. Perfusion Solutions, Inc.
16.10. Lifeline Scientific Inc.
17. STRATEGIC RECOMMENDATIONS
18. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. IMPACT OF COVID-19 ON GLOBAL ORGAN PRESERVATION SOLUTION MARKET
5. GLOBAL ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Organ Type (Heart, Lung, Kidney, Liver, Others)
5.2.2. By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others)
5.2.3. By Region
5.2.4. By Company (2023)
5.3. Market Map
6. ASIA PACIFIC ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Organ Type
6.2.2. By Application
6.2.3. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Organ Preservation Solution Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Organ Type
6.3.1.2.2. By Application
6.3.2. India Organ Preservation Solution Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Organ Type
6.3.2.2.2. By Application
6.3.3. Australia Organ Preservation Solution Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Organ Type
6.3.3.2.2. By Application
6.3.4. Japan Organ Preservation Solution Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Organ Type
6.3.4.2.2. By Application
6.3.5. South Korea Organ Preservation Solution Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Organ Type
6.3.5.2.2. By Application
7. EUROPE ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Organ Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Organ Preservation Solution Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Organ Type
7.3.1.2.2. By Application
7.3.2. Germany Organ Preservation Solution Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Organ Type
7.3.2.2.2. By Application
7.3.3. Spain Organ Preservation Solution Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Organ Type
7.3.3.2.2. By Application
7.3.4. Italy Organ Preservation Solution Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Organ Type
7.3.4.2.2. By Application
7.3.5. United Kingdom Organ Preservation Solution Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Organ Type
7.3.5.2.2. By Application
8. NORTH AMERICA ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Organ Type
8.2.2. By Application
8.2.3. By Country
8.3. North America: Country Analysis
8.3.1. United States Organ Preservation Solution Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Organ Type
8.3.1.2.2. By Application
8.3.2. Mexico Organ Preservation Solution Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Organ Type
8.3.2.2.2. By Application
8.3.3. Canada Organ Preservation Solution Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Organ Type
8.3.3.2.2. By Application
9. SOUTH AMERICA ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Organ Type
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Organ Preservation Solution Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Organ Type
9.3.1.2.2. By Application
9.3.2. Argentina Organ Preservation Solution Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Organ Type
9.3.2.2.2. By Application
9.3.3. Colombia Organ Preservation Solution Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Organ Type
9.3.3.2.2. By Application
10. MIDDLE EAST AND AFRICA ORGAN PRESERVATION SOLUTION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Organ Type
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Organ Preservation Solution Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Organ Type
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Organ Preservation Solution Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Organ Type
10.3.2.2.2. By Application
10.3.3. UAE Organ Preservation Solution Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Organ Type
10.3.3.2.2. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL ORGAN PRESERVATION SOLUTION MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. PESTLE ANALYSIS
16. COMPETITIVE LANDSCAPE
16.1. Waters Medical Systems LLC
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.2. Xvivo Perfusion AB
16.3. TransMedics Inc
16.4. Organox Limited
16.5. 21st Century Medicine
16.6. Dr. Franz Koehler Chemie GmbH
16.7. Accord Healthcare Limited
16.8. Bridge to Life Ltd
16.9. Perfusion Solutions, Inc.
16.10. Lifeline Scientific Inc.
17. STRATEGIC RECOMMENDATIONS
18. ABOUT US & DISCLAIMER
